This is a clinical trial for adults 18-50 years old with schizophrenia and cognitive impairment. The purpose of the trial is to evaluate whether an investigational medication can improve cognitive impairment (e.g., concentration, memory, reasoning, and problem-solving) and daily functioning in schizophrenia patients.

The below screening questions will ask for contact and background information along with diagnoses and symptoms you have and medications you take. Answering the below screening questions is voluntary, and you may opt out of the screener at any time.

Your answers will be recorded on a secured password-protected platform. Only approved study staff can see the data.

By clicking submit on the form below, you agree that if you’re not qualified for this study, you consent for your information to be retained in order for us to contact you about other research opportunities you may be a fit for.